KLK3 and prostate carcinoma: They created a classification and regression tree (CART) model that, regardless of the prostate specific antigen (PSA) level, could be applied to patients referred for an abnormal PSA level, a digital rectal examination (DRE), or both in order to recognize patients with severe prostate cancer (PCa) on prostate biopsy.